Financial Snapshot

Revenue
$10.21M
TTM
Gross Margin
40.06%
TTM
Net Earnings
-$21.17M
TTM
Current Assets
Q3 2024
Current Liabilities
Q3 2024
Current Ratio
37.14%
Q3 2024
Total Assets
Q3 2024
Total Liabilities
Q3 2024
Book Value
$14.61M
Q3 2024
Cash
Q3 2024
P/E
-0.04636
Nov 29, 2024 EST
Free Cash Flow
-$660.0K
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007
Revenue $13.29M $12.57M $11.74M $9.305M $7.860M $9.420M $8.890M $7.960M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change 5.75% 7.11% 26.14% 18.39% -16.56% 5.96% 11.68%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007
Revenue $13.29M $12.57M $11.74M $9.305M $7.860M $9.420M $8.890M $7.960M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Cost Of Revenue $7.552M $7.619M $6.939M $5.482M $4.800M $5.900M $5.470M $4.990M
Gross Profit $5.743M $4.953M $4.799M $3.823M $3.060M $3.520M $3.420M $2.980M
Gross Profit Margin 43.2% 39.39% 40.89% 41.08% 38.93% 37.37% 38.47% 37.44%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007
Selling, General & Admin $14.06M $13.51M $14.39M $8.097M $7.290M $4.060M $4.990M $3.090M $0.00 $240.0K
YoY Change 4.08% -6.11% 77.66% 11.07% 79.56% -18.64% 61.49% -100.0%
% of Gross Profit 244.78% 272.7% 299.74% 211.8% 238.24% 115.34% 145.91% 103.69%
Research & Development $0.00 $0.00 $150.0K $210.0K $110.0K $140.0K $290.0K
YoY Change -100.0% -28.57% 90.91% -21.43% -51.72% 11.54%
% of Gross Profit
Depreciation & Amortization $259.5K $292.0K $323.0K $1.724M $1.450M $100.0K $70.00K $70.00K $0.00 $0.00 $10.00K $0.00 $150.0K $40.00K $60.00K $10.00K $20.00K $10.00K
YoY Change -11.14% -9.6% -81.26% 18.9% 1350.0% 42.86% 0.0% -100.0% -100.0% 275.0% -33.33% 500.0% -50.0% 100.0%
% of Gross Profit 4.52% 5.9% 6.73% 45.1% 47.39% 2.84% 2.05% 2.35%
Operating Expenses $15.82M $13.51M $29.83M $8.097M $7.300M $4.060M $4.990M $3.090M $160.0K $400.0K $570.0K $450.0K $820.0K $2.220M $2.330M $1.980M $960.0K $2.490M
YoY Change 17.13% -54.72% 268.35% 10.92% 79.8% -18.64% 61.49% 1831.25% -60.0% -29.82% 26.67% -45.12% -63.06% -4.72% 17.68% 106.25% -61.45% 70.55%
Operating Profit -$10.08M -$8.553M -$25.03M -$4.274M -$4.240M -$540.0K -$1.570M -$110.0K
YoY Change 17.81% -65.82% 485.53% 0.81% 685.19% -65.61% 1327.27%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007
Interest Expense $652.4K $360.6K $1.594M -$119.3K -$120.0K -$70.00K -$550.0K -$520.0K $0.00 -$2.400M -$560.0K -$440.0K -$340.0K -$10.00K -$240.0K -$290.0K -$20.00K $20.00K
YoY Change 80.93% -77.38% -1436.25% -0.58% 71.43% -87.27% 5.77% -100.0% 328.57% 27.27% 29.41% 3300.0% -95.83% -17.24% 1350.0% -200.0%
% of Operating Profit
Other Income/Expense, Net -$6.052M -$4.716M -$8.041M -$97.42K -$190.0K $70.00K $0.00 $30.00K $100.0K
YoY Change 28.33% -41.35% 8154.09% -48.73% -371.43% -100.0% -70.0%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007
Pretax Income -$16.13M -$13.27M -$33.07M -$4.471M -$4.920M -$400.0K -$2.120M -$630.0K -$160.0K -$2.770M -$1.030M -$890.0K -$1.160M -$2.240M -$2.570M -$2.270M -$980.0K -$2.470M
YoY Change 21.55% -59.87% 639.61% -9.13% 1130.0% -81.13% 236.51% 293.75% -94.22% 168.93% 15.73% -23.28% -48.21% -12.84% 13.22% 131.63% -60.32% 68.03%
Income Tax -$22.30K $0.00 $0.00 $110.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$16.17M -$13.21M -$32.85M -$4.462M -$4.920M -$390.0K -$2.110M -$740.0K -$160.0K -$2.770M -$1.030M -$890.0K -$1.160M -$2.240M -$2.570M -$2.270M -$980.0K -$2.470M
YoY Change 22.34% -59.77% 636.17% -9.31% 1161.54% -81.52% 185.14% 362.5% -94.22% 168.93% 15.73% -23.28% -48.21% -12.84% 13.22% 131.63% -60.32% 68.03%
Net Earnings / Revenue -121.61% -105.11% -279.86% -47.95% -62.6% -4.14% -23.73% -9.3%
Basic Earnings Per Share -$0.89 -$1.30 -$1.13 -$0.18
Diluted Earnings Per Share -$0.89 -$1.30 -$1.13 -$180.1K -$213.6K -$17.95K -$101.6K -$41.64K -$71.43K -$1.325M -$631.9K -$1.156M -$3.515M -$8.615M -$11.68M -$15.13M -$10.89M -$30.88M

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007
Cash & Short-Term Investments $416.3K $2.179M $8.293M $2.070M $2.080M $680.0K $1.900M $50.00K $10.00K $0.00 $0.00 $10.00K $10.00K $130.0K $600.0K $0.00 $0.00
YoY Change -80.89% -73.73% 300.64% -0.48% 205.88% -64.21% 3700.0% 400.0% -100.0% 0.0% -92.31% -78.33%
Cash & Equivalents $416.3K $2.179M $8.293M $2.070M $2.080M $680.0K $1.900M
Short-Term Investments $0.00
Other Short-Term Assets $346.2K $571.3K $218.4K $190.0K $250.0K $160.0K $250.0K $0.00 $350.0K $10.00K $10.00K $110.0K $10.00K $0.00 $0.00
YoY Change -39.41% 161.63% 14.94% -24.0% 56.25% -36.0% 3400.0% 0.0% -90.91% 1000.0%
Inventory $1.107M $879.0K $339.4K
Prepaid Expenses
Receivables $1.467M $1.017M $1.468M $1.730M $1.460M $1.340M $1.130M
Other Receivables $1.052M $1.085M $814.2K $310.0K $300.0K $390.0K $370.0K
Total Short-Term Assets $4.388M $5.732M $11.13M $4.290M $4.100M $2.570M $3.650M $60.00K $10.00K $0.00 $350.0K $20.00K $20.00K $240.0K $610.0K $10.00K $10.00K
YoY Change -23.44% -48.52% 159.52% 4.63% 59.53% -29.59% 5983.33% 500.0% -100.0% 1650.0% 0.0% -91.67% -60.66% 6000.0% 0.0%
Property, Plant & Equipment $7.374M $8.475M $8.614M $3.160M $3.410M $400.0K $300.0K $0.00 $10.00K $10.00K $20.00K $10.00K $10.00K $10.00K $10.00K $30.00K
YoY Change -12.99% -1.61% 172.59% -7.33% 752.5% 33.33% -100.0% 0.0% -50.0% 100.0% 0.0% 0.0% 0.0% -66.67%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $290.0K $1.060M $60.00K
YoY Change -72.64% 1666.67%
Other Assets $0.00 $380.0K $720.0K $1.110M $1.160M
YoY Change -100.0% -47.22% -35.14% -4.31%
Total Long-Term Assets $31.17M $35.14M $50.82M $31.10M $28.17M $2.170M $1.860M $10.00K $20.00K $20.00K $10.00K $10.00K $10.00K $950.0K $10.00K $10.00K $30.00K
YoY Change -11.29% -30.86% 63.42% 10.4% 1198.16% 16.67% 18500.0% -50.0% 0.0% 100.0% 0.0% 0.0% -98.95% 9400.0% 0.0% -66.67%
Total Assets $35.56M $40.87M $61.96M $35.39M $32.27M $4.740M $5.510M $70.00K $30.00K $20.00K $360.0K $30.00K $30.00K $1.190M $620.0K $20.00K $40.00K
YoY Change
Accounts Payable $3.514M $1.800M $1.450M $880.0K $1.140M $1.310M $1.700M $20.00K $10.00K $80.00K $150.0K $120.0K $120.0K $160.0K $140.0K $170.0K $80.00K
YoY Change 95.18% 24.18% 64.75% -22.81% -12.98% -22.94% 8400.0% 100.0% -87.5% -46.67% 25.0% 0.0% -25.0% 14.29% -17.65% 112.5%
Accrued Expenses $1.996M $2.116M $1.988M $1.100M $960.0K $540.0K $740.0K $0.00 $40.00K $30.00K $30.00K $20.00K $920.0K $70.00K $850.0K $610.0K
YoY Change -5.64% 6.43% 80.71% 14.58% 77.78% -27.03% -100.0% 33.33% 0.0% 50.0% -97.83% 1214.29% -91.76% 39.34%
Deferred Revenue
YoY Change
Short-Term Debt $1.092M $9.579M $478.9K $610.0K $920.0K $1.120M $1.810M $0.00 $0.00 $0.00 $10.00K $100.0K $10.00K $0.00 $0.00 $0.00 $0.00
YoY Change -88.6% 1900.03% -21.49% -33.7% -17.86% -38.12% -100.0% -90.0% 900.0%
Long-Term Debt Due $1.206M $8.890K $4.509M $0.00 $380.0K $10.00K $0.00 $220.0K $380.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change 13465.47% -99.8% -100.0% 3700.0% -100.0% -42.11%
Total Short-Term Liabilities $7.905M $14.07M $8.464M $2.600M $3.030M $3.350M $4.270M $20.00K $10.00K $340.0K $560.0K $240.0K $140.0K $1.080M $210.0K $1.020M $690.0K
YoY Change -43.84% 66.29% 225.54% -14.19% -9.55% -21.55% 21250.0% 100.0% -97.06% -39.29% 133.33% 71.43% -87.04% 414.29% -79.41% 47.83%
Long-Term Debt $65.04K $1.120M $6.132M $950.0K $1.200M $1.220M $5.530M $0.00 $0.00 $310.0K $120.0K $0.00 $10.00K $0.00 $0.00 $50.00K $0.00
YoY Change -94.19% -81.74% 545.48% -20.83% -1.64% -77.94% -100.0% 158.33% -100.0% -100.0%
Other Long-Term Liabilities $1.694M $2.185M $2.058M $2.270M $2.500M $630.0K $590.0K $2.210M $1.600M $1.300M $390.0K $340.0K
YoY Change -22.5% 6.2% -9.35% -9.2% 6.78% -73.3% 38.13% 23.08% 233.33% 14.71%
Total Long-Term Liabilities $1.759M $3.305M $8.190M $3.220M $3.700M $1.220M $5.530M $0.00 $0.00 $310.0K $750.0K $590.0K $2.220M $1.600M $1.300M $440.0K $340.0K
YoY Change -46.79% -59.64% 154.34% -12.97% 203.28% -77.94% -100.0% -58.67% 27.12% -73.42% 38.75% 23.08% 195.45% 29.41%
Total Liabilities $10.75M $18.57M $18.09M $5.770M $6.690M $4.540M $9.780M $20.00K $10.00K $650.0K $1.310M $830.0K $2.350M $2.680M $1.510M $1.460M $1.030M
YoY Change -42.12% 2.62% 213.59% -13.75% 47.36% -53.58% 48800.0% 100.0% -98.46% -50.38% 57.83% -64.68% -12.31% 77.48% 3.42% 41.75%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007
Basic Shares Outstanding 18.03M shares 10.17M shares 29.12M shares 24.77M shares
Diluted Shares Outstanding 18.03M shares 10.17M shares 2.913M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $981.31 Thousand

About Novo Integrated Sciences, Inc.

Novo Integrated Sciences, Inc. engages in the provision of medical services. The company is headquartered in Bellevue, Washington and currently employs 127 full-time employees. The company went IPO on 2005-07-12. The firm owns Canadian and United States subsidiaries that provide, or intend to provide, essential and differentiated solutions to the delivery of multidisciplinary primary care and related wellness products through the integration of medical technology, interconnectivity, advanced therapeutic, diagnostic solutions, personalized product offerings, and rehabilitative science. The firm operates through two segments: Healthcare Services and Product Sales. Its specialized multidisciplinary primary healthcare services include physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, dietician and others. Its subsidiaries include Novo Healthnet Limited, Novomerica Health Group, Inc., PRO-DIP, LLC and others.

Industry: Engines & Turbines Peers: BIODESIX INC Clearday, Inc. CRYO CELL INTERNATIONAL INC CVS HEALTH Corp Stella Diagnostics, Inc. WeCapital Holdings, Inc. PSYCHEMEDICS CORP Precipio, Inc. Vivos Therapeutics, Inc.